CAR T therapy

A study by Joseph Fraietta, Frederic Bushman, and Carl June of the Perelman School of Medicine found no evidence that CAR T therapy causes any type of secondary cancer in modified T cells, reaffirming the safety of a groundbreaking cancer treatment. “We aim to continue to make CAR T cell therapy even safer and more effective so that more patients and their families can benefit from this lifesaving therapy,”June says.